We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.71%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
+$684M
(+16%)
Cap. Flow
+$419M
Cap. Flow
% of AUM
8.22%
Top 10 Holdings %
Top 10 Hldgs %
29.02%
Holding
1,104
New
355
Increased
287
Reduced
198
Closed
246
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$115M |
| 2 |
Bausch Health
BHC
|
+$84M |
| 3 |
Brookdale Senior Living
BKD
|
+$72M |
| 4 |
Abbott
ABT
|
+$56.3M |
| 5 |
AET
Aetna Inc
AET
|
+$56.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$160M |
| 2 |
Perrigo
PRGO
|
+$122M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$115M |
| 4 |
Amgen
AMGN
|
+$82M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$36.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.19% |
| 2 | Miscellaneous | 8.84% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Consumer Staples | 5.73% |
| 5 | Utilities | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HCBK
451
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $968K | 0.02% |
+102,661
| New | +$942K |
|
452
Wells Fargo
WFC
$263B
| $959K | 0.02% |
21,124
-27,070
| -56% | -$1.17M |
|
453
Agilent Technologies
A
$43.3B
| $957K | 0.02% |
23,396
-638,946
| -96% | -$24.3M |
|
|
VPHM
454
DELISTED
VIROPHARMA INC
VPHM
| $952K | 0.02% |
19,107
-27,993
| -59% | -$1.25M |
|
455
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.1B
| $943K | 0.02% |
3,971
-2,091
| -34% | -$194K |
|
|
SCU
456
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $937K | 0.02% |
+6,328
| New | +$834K |
|
457
Edwards Lifesciences
EW
$51.5B
| $932K | 0.02% |
85,032
-1,713,918
| -95% | -$19.3M |
|
458
Middleby
MIDD
$5.08B
| $930K | 0.02% |
+11,628
| New | +$861K |
|
459
State Street Materials Select Sector SPDR ETF
XLB
$8.33B
| $924K | 0.02% |
40,000
+16,000
| +67% | +$352K |
|
460
PG&E
PCG
$29.4B
| $918K | 0.02% |
22,800
+1,200
| +6% | +$49.2K |
|
|
ATW
461
DELISTED
Atwood Oceanics
ATW
| $906K | 0.02% |
+16,973
| New | +$916K |
|
462
Dollar General
DG
$27.1B
| $903K | 0.02% |
14,964
+10,881
| +266% | +$639K |
|
|
DVM
463
DELISTED
COHEN & STEERS DIV MAJORS FUND INC
DVM
| $888K | 0.02% |
60,921
+800
| +1% | +$11.3K |
|
464
Goldman Sachs
GS
$273B
| $873K | 0.02% |
+4,925
| New | +$812K |
|
465
Teradata
TDC
$2.71B
| $873K | 0.02% |
+19,188
| New | +$870K |
|
466
KBR
KBR
$4.61B
| $867K | 0.02% |
+27,173
| New | +$903K |
|
467
UGI
UGI
$8.19B
| $867K | 0.02% |
31,380
+21,238
| +209% | +$572K |
|
468
TechnipFMC
FTI
$28.5B
| $856K | 0.02% |
22,034
+4,965
| +29% | +$193K |
|
|
CERN
469
DELISTED
Cerner Corp
CERN
| $850K | 0.02% |
+15,249
| New | +$855K |
|
470
PTC Therapeutics
PTCT
$5.64B
| $848K | 0.02% |
50,000
-600
| -1% | -$10.5K |
|
|
RDA
471
DELISTED
RDA MICROELECTRONICS INC SPONSORED ADR
RDA
| $848K | 0.02% |
+47,406
| New | +$788K |
|
|
ACOR
472
DELISTED
Acorda Therapeutics
ACOR
| $840K | 0.02% |
240
-28
| -10% | -$109K |
|
|
TXNM
473
TXNM Energy Inc
TXNM
$6.03B
| $839K | 0.02% |
+34,754
| New | +$813K |
|
474
Agios Pharmaceuticals
AGIO
$1.97B
| $838K | 0.02% |
35,000
-600
| -2% | -$13.7K |
|
475
ManpowerGroup
MAN
$2.69B
| $833K | 0.02% |
9,700
+5,720
| +144% | +$457K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2013 Portfolio in Review
As of Q4 2013, Visium Asset Management held 1,104 positions worth $5.09B, up 16% from $4.41B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Visium Asset Management deployed $419M of net new capital in Q4 2013, opening 355 new positions and adding to 287 existing holdings. Its largest new stake was Bausch Health: 766,970 shares worth $90M.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 55% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $122M trimmed.
- Visium Asset Management's largest Q4 2013 buy was Bausch Health: 766,970 shares worth $90M.
- Visium Asset Management added most to Allergan plc in Q4 2013, an estimated $115M increase.
- Visium Asset Management's biggest Q4 2013 reduction was Perrigo, cutting an estimated $122M.
- Visium Asset Management fully exited WARNER CHILCOTT PLC ORD SHS CL A (IRL) in Q4 2013, selling an estimated $160M.
- Visium Asset Management's ten largest holdings make up 29% of its $5.09B portfolio in Q4 2013.
- Visium Asset Management opened 355 new positions and closed 246 in Q4 2013.
- Visium Asset Management's portfolio value rose 16% quarter-over-quarter to $5.09B.
Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.